Compounds, compositions and methods are provided for modulating the
expression of STAT5. The compositions comprise oligonucleotides, targeted
to nucleic acid encoding STAT5. Methods of using these compounds for
modulation of STAT5 expression and for diagnosis and treatment of
diseases and conditions associated with expression of STAT5 are provided.
